Mina Ibrahim Tadros
- Pharmaceutical Science top 0.1%
- Molecular Biology
- Biomaterials top 5%
- Public Health, Environmental and Occupational Health top 10%
- Food Science top 10%
- Co-authors
- Mohamed A. El-NabarawiSaadia A. TayelWessam H. Abd-ElsalamAhmed AbdelbaryHanan M. El-LaithyEhab R. BendasGhada A. AbdelbaryMagdy I. Mohamed
- Topics
- Advanced Drug Delivery Systems (27 papers)Drug Solubulity and Delivery Systems (24 papers)Advancements in Transdermal Drug Delivery (15 papers)
- Journals
- SHILAP Revista de lepidopterologíaInternational Journal of PharmaceuticsEuropean Journal of Pharmaceutics and Biopharmaceutics
In The Last Decade
Mina Ibrahim Tadros
49 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 109
- Pharmaceutical Science 1.2k
- Molecular Biology 298
- Biomaterials 272
- Public Health, Environmental and Occupational Health 173
- Food Science 147
Countries citing papers authored by Mina Ibrahim Tadros
This map shows the geographic impact of Mina Ibrahim Tadros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Ibrahim Tadros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Ibrahim Tadros more than expected).
Fields of papers citing papers by Mina Ibrahim Tadros
This network shows the impact of papers produced by Mina Ibrahim Tadros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Ibrahim Tadros. The network helps show where Mina Ibrahim Tadros may publish in the future.
Co-authorship network of co-authors of Mina Ibrahim Tadros
This figure shows the co-authorship network connecting the top 25 collaborators of Mina Ibrahim Tadros. A scholar is included among the top collaborators of Mina Ibrahim Tadros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Ibrahim Tadros. Mina Ibrahim Tadros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 20 | |
| 4 | 5 | |
| 5 | 52 | |
| 6 | 34 | |
| 7 | 49 | |
| 8 | 11 | |
| 9 | 6 | |
| 10 | 19 | |
| 11 | 23 | |
| 12 | DEVELOPMENT AND IN VITRO EVALUATION OF MUCOADHESIVE BILAYER BUCCAL TABLETS OF CARVEDILOL | 6 |
| 13 | 84 | |
| 14 | 19 | |
| 15 | 54 | |
| 16 | 155 | |
| 17 | 21 | |
| 18 | 45 | |
| 19 | 122 | |
| 20 | 41 |
About Mina Ibrahim Tadros
Mina Ibrahim Tadros is a scholar working on Pharmaceutical Science, Molecular Medicine and Analytical Chemistry, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (27 papers), Drug Solubulity and Delivery Systems (24 papers) and Advancements in Transdermal Drug Delivery (15 papers). The work is most often cited by research in Pharmaceutical Science (1.2k citations), Biomaterials (272 citations) and Molecular Medicine (102 citations). Mina Ibrahim Tadros has collaborated with scholars based in Egypt, Brazil and Iraq. Frequent co-authors include Mohamed A. El-Nabarawi, Saadia A. Tayel, Wessam H. Abd-Elsalam, Ahmed Abdelbary, Hanan M. El-Laithy, Ehab R. Bendas, Ghada A. Abdelbary, Magdy I. Mohamed, Hussein O. Ammar and Aliaa Nabil ElMeshad. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.